|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/437 | |
| A61K 38/13 | |||
| A61P 1/00 | |||
| A61P 1/12 |
| (11) | Patento numeris | 3160467 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15815195.1 |
| Europos patento paraiškos padavimo data | 2015-05-04 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-05-03 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-03-10 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2015/029083 |
| Data | 2015-05-04 |
| (87) | Numeris | WO 2016/003536 |
| Data | 2016-01-07 |
| (30) | Numeris | Data | Šalis |
| 201462019388 P | 2014-06-30 | US | |
| 201462036097 P | 2014-08-11 | US |
| (72) |
GOLDEN, Pam, US
BORTEY, Enoch, US
FORBES, William, US
PATERSON, Craig, US
|
| (73) |
Salix Pharmaceuticals, Inc.,
400 Somerset Corporate Boulevard, Bridgewater, NJ 08807,
US
|
| (54) | COMBINATION COMPRISING RIFAXIMIN AND CYCLOSPORINE FOR USE IN THE TREATMENT OF BOWEL DISEASES |
| COMBINATION COMPRISING RIFAXIMIN AND CYCLOSPORINE FOR USE IN THE TREATMENT OF BOWEL DISEASES |